Bioavailability of ibuprofen following oral administration of standard ibuprofen, sodium ibuprofen or ibuprofen acid incorporating poloxamer in healthy volunteers

BMC Clinical Pharmacology

Volumn 9, Issue , 2009, Pages

  Dewland, Peter M ^a   Reader, Sandie ^b   Berry, Phillip ^b  

^a SIMBEC RESEARCH LTD   (United Kingdom)

^b RECKITT BENCKISER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

IBUPROFEN; IBUPROFEN DERIVATIVE; POLOXAMER; SODIUM IBUPROFEN; UNCLASSIFIED DRUG;

ADULT; AREA UNDER THE CURVE; ARTICLE; BIOEQUIVALENCE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG DOSAGE FORM COMPARISON; DRUG FORMULATION; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; MAXIMUM PLASMA CONCENTRATION; NORMAL HUMAN; RANDOMIZED CONTROLLED TRIAL; SINGLE DRUG DOSE; TIME TO MAXIMUM PLASMA CONCENTRATION; ADOLESCENT; BIOAVAILABILITY; CHEMISTRY; COMPARATIVE STUDY; CROSSOVER PROCEDURE; DRUG COMBINATION; MIDDLE AGED; ORAL DRUG ADMINISTRATION;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; BIOLOGICAL AVAILABILITY; CHEMISTRY, PHARMACEUTICAL; CROSS-OVER STUDIES; DRUG COMBINATIONS; FEMALE; HUMANS; IBUPROFEN; MALE; MIDDLE AGED; POLOXAMER; YOUNG ADULT;

EID: 74549163584     PISSN: None     EISSN: 14726904     Source Type: Journal    
DOI: 10.1186/1472-6904-9-19     Document Type: Article

References (22)

1. Davies NM. Clinical pharmacokinetics of ibuprofen. The first 30 years. Clin Pharmacokinet 1998, 34:101-154. 10.2165/00003088-199834020-00002, 9515184.
2. Neupert W, Brugger R, Euchenhofer C, Brune K, Geisslinger G. Effects of ibuprofen enantiomers and its coenzyme A thioesters on human prostaglandin endoperoxide synthases. Br J Pharmacol 1997, 122:487-492. 10.1038/sj.bjp.0701415, 1564971, 9351505.
3. Martinez MN, Amidon GL. A mechanistic approach to understanding the factors affecting drug absorption: a review of fundamentals. J Clin Pharmacol 2002, 42:620-643. 10.1177/00970002042006005, 12043951.
4. Albert KS, Gernaat CM. Pharmacokinetics of ibuprofen. Am J Med 1984, 77:40-46.
5. Laska EM, Sunshine A, Marrero I, Olson N, Siegel C, McCormick N. The correlation between blood levels of ibuprofen and clinical analgesic response. Clin Pharmacol Ther 1986, 40:1-7.
6. Mehlisch DR, Ardia A, Pallotta T. A controlled comparative study of ibuprofen arginate versus conventional ibuprofen in the treatment of postoperative dental pain. J Clin Pharmacol 2002, 42:904-911. 10.1177/009127002401102821, 12162473.
7. Geisslinger G, Dietzel K, Bezler H, Nuernberg B, Brune K. Therapeutically relevant differences in the pharmacokinetical and pharmaceutical behavior of ibuprofen lysinate as compared to ibuprofen acid. Int J Clin Pharmacol Ther Toxicol 1989, 27:324-328.
8. Johnson ES, Ratcliffe DM, Wilkinson M. Naproxen sodium in the treatment of migraine. Cephalalgia 1985, 5:5-10. 10.1046/j.1468-2982.1985.0501005.x, 3886154.
9. Sorgel F, Fuhr U, Minic M, Siegmund M, Maares J, Jetter A, Kinzig-Schippers M, Tomalik-Scharte D, Szymanski J, Goeser T, Toex U, Scheidel B, Lehmacher W. Pharmacokinetics of ibuprofen sodium dihydrate and gastrointestinal tolerability of short-term treatment with a novel, rapidly absorbed formulation. Int J Clin Pharmacol Ther 2005, 43:140-149.
10. Martin W, Koselowske G, Toberich H, Kerkmann T, Mangold B, Augustin J. Pharmacokinetics and absolute bioavailability of ibuprofen after oral administration of ibuprofen lysine in man. Biopharm Drug Dispos 1990, 11:265-278. 10.1002/bdd.2510110311, 2109643.
11. Klueglich M, Ring A, Scheuerer S, Trommeshauser D, Schuijt C, Liepold B, Berndl G. Ibuprofen extrudate, a novel, rapidly dissolving ibuprofen formulation: relative bioavailability compared to ibuprofen lysinate and regular ibuprofen, and food effect on all formulations. J Clin Pharmacol 2005, 45:1055-1061. 10.1177/0091270005279579, 16100300.
12. Schleier P, Prochnau A, Schmidt-Westhausen AM, Peters H, Becker J, Latz T, Jackowski J, Peters EU, Romanos GE, Zahn B, Lüdemann J, Maares J, Petersen B. Ibuprofen sodium dihydrate, an ibuprofen formulation with improved absorption characteristics, provides faster and greater pain relief than ibuprofen acid. Int J Clin Pharmacol Ther 2007, 45:89-97.
13. Black P, Max MB, Desjardins P, Norwood T, Ardia A, Pallotta T. A randomized, double-blind, placebo-controlled comparison of the analgesic efficacy, onset of action, and tolerability of ibuprofen arginate and ibuprofen in postoperative dental pain. Clin Ther 2002, 24:1072-1089. 10.1016/S0149-2918(02)80020-0, 12182253.
14. Desjardins P, Black P, Papageorge M, Norwood T, Shen DD, Norris L, Ardia A. Ibuprofen arginate provides effective relief from postoperative dental pain with a more rapid onset of action than ibuprofen. Eur J Clin Pharmacol 2002, 58:387-394. 10.1007/s00228-002-0491-0, 12242597.
15. Newa M, Bhandari KH, Oh DH, Kim YR, Sung JH, Kim JO, Woo JS, Choi HG, Yong CS. Enhanced dissolution of ibuprofen using solid dispersion with poloxamer 407. Arch Pharm Res 2008, 31:1497-1507. 10.1007/s12272-001-2136-8, 19023548.
16. World Medical Association Declaration of Helsinki: Ethical Principles for Medical Research Involving Human Patients. Adopted by the 18th WMA General Assembly 1964 and amended by the 29th, 35th, 41st and 48th WMA General Assemblies
17. Directive 2001/20/EC of the European Parliament and of the Council on the approximation of the laws, regulations and administrative provisions of the Member States relating to the implementation of good clinical practice in the conduct of clinical trials on medicinal products for human use. , http://www.wctn.org.uk/downloads/EU_Directive/Directive.pdf
18. Diletti E, Hauschke D, Steinijans VW. Sample size determination for bioequivalence assessment by means of confidence intervals. Int J Clin Pharmacol Ther Toxicol 1991, 29:1-8.
19. Schettler T, Paris S, Pellett M, Kidner S, Wilkinson D. Comparative pharmacokinetics of two fast-dissolving oral ibuprofen formulations and a regular-release ibuprofen tablet in healthy volunteers. Clin Drug Investig 2001, 21:73-78.
20. Note for Guidance on the Investigation of Bioavailability and Bioequivalence. CPMP/EWP/QWP/1401/98 2002, , http://www.emea.europa.eu/pdfs/human/qwp/140198enrev1.pdf
21. Guidance for Industry. Statistical approaches to establishing bioequivalence. FDA 2001, , http://www.fda.gov/downloads/Drugs/.../Guidances/ucm070244.pdf
22. Daniels S, Reader S, Berry P, Goulder M. Onset of analgesia with sodium ibuprofen, ibuprofen acid and incorporating poloxamer and acetaminophen - a single-dose, double-blind, placebo-controlled study in patients with post-operative dental pain. Eur J Clin Pharmacol 2009, 65:343-353. 10.1007/s00228-009-0614-y, 19252905.